Ketamine may cut opioid use after major aortic surgery
NCT ID NCT04600089
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a low dose of ketamine can reduce the amount of strong painkillers (opioids) needed and improve pain control in people recovering from thoracic endovascular aortic repair (TEVAR). About 30 adults scheduled for this surgery will receive either ketamine or a placebo alongside standard care. The goal is to see if ketamine can safely spare opioid use while managing pain effectively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESCENDING AORTIC DISSECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kentucky Medical Center
RECRUITINGLexington, Kentucky, 40536, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can patients safely dispense their own pain medicine after surgery?
- Can a VR headset calm nerves before surgery?
- Can a less invasive nerve block match the gold standard for chest surgery pain?
- Could a Pre-Surgery nerve block speed up recovery after hip fracture?
- One injection or many? a test to ease breast surgery pain
- One injection vs. two: a new approach to shoulder surgery pain?